RSS Feed
Blood Cancer Meeting Abstracts Released: BioBuzz
No data in Celgene abstract, disappointing investors.
11:14AM 11/10/09
Bristol Licenses Arthritis Drug: BioBuzz
Worldwide deal involves privately held Alder BioTherapeutics
09:20AM 11/10/09
Celgene in ASH Abstract Spotlight: BioBuzz
A blood cancer meeting also is important for Onyx, Cephalon and Ariad.
06:31AM 11/10/09
Doc Offers Top Hep C Drug Picks: BioBuzz
Vertex, InterMune, Pharmasset get positive reviews after recent Hep C meeting.
01:54PM 11/09/09
Xoma Waffles on Timing of Drug Partnership: BioBuzz
An expected deal for its diabetes drug may not happen until next year.
10:23AM 11/09/09
Ariad Upgraded, Xenoport Drug Delayed: BioBuzz
Analysts sees upside in two Ariad drugs while FDA delays decision on Xenoport drug.
07:51AM 11/09/09
Oculus, Bianco and Cel-Sci Oh My!: BioBuzz
Some Friday Fall tidbits from the biotech stock world.
10:53AM 11/06/09
Biotech Stock Mailbag: Poniard Predictions
Readers chime in on Poniard Pharmaceuticals, Chelsea Therapeutics, AMAG, Cel-Sci and Dendreon.
07:00AM 11/06/09
BioCryst Competition for IV Flu Drug: BioBuzz
U.S. government orders IV versions of two flu drugs to treat hospitalized patients.
06:29AM 11/06/09
BioCryst Winners and Losers: BioBuzz
Sorting out the latest salvo in the H1N1 investor war
02:32PM 11/05/09
Connect with TheStreet